Patents by Inventor Hervé Nozach

Hervé Nozach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOF
    Publication number: 20230234994
    Abstract: A peptide may include a sequence having 80% or more amino acid identity with the amino acid sequence of SEQ ID NO. 1, i.e., RPSX1CNLPVKPGPCX2GFFSAFYYSQKX3NKCHSFTYGGCAGNANRFSTX4EKCRRTC X5X6, wherein, X1 is the amino acid residue F or G, X2 is any amino acid residue, except a basic amino acid residue, X3 is the amino acid residue T or D, X4 is the amino acid residue I, L, or E, (i) X5 is V and X6 is G or (ii) X5 is G and X6 is V, and the amino acid located at position 39 is A. Such peptides may have various diagnostic and therapeutic uses.
    Type: Application
    Filed: June 23, 2021
    Publication date: July 27, 2023
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Nicolas GILLES, Justyna CIOLEK, Laura DROCTOVE, Bernard MAILLERE, Herve NOZACH
  • Adalimumab Variants with Reduced Immunogenic Potential
    Publication number: 20230142800
    Abstract: The invention relates to adalimumab variants with reduced immunogenic potential and retained or increased affinity and therapeutic applications thereof.
    Type: Application
    Filed: December 17, 2020
    Publication date: May 11, 2023
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Hervé Nozach, Coline Sivelle, Raphaël Sierocki, Bernard Maillere